%0 Journal Article %A Alexander Crits-Christoph %A Rose S. Kantor %A Matthew R. Olm %A Oscar N. Whitney %A Basem Al-Shayeb %A Yue C. Lou %A Avi Flamholz %A Lauren C. Kennedy %A Hannah Greenwald %A Adrian Hinkle %A Jonathan Hetzel %A Sara Spitzer %A Jeffery Koble %A Asako Tan %A Fred Hyde %A Gary Schroth %A Scott Kuersten %A Jillian F. Banfield %A Kara L. Nelson %T Genome sequencing of sewage detects regionally prevalent SARS-CoV-2 variants %D 2020 %R 10.1101/2020.09.13.20193805 %J medRxiv %P 2020.09.13.20193805 %X Viral genome sequencing has guided our understanding of the spread and extent of genetic diversity of SARS-CoV-2 during the COVID-19 pandemic. SARS-CoV-2 viral genomes are usually sequenced from nasopharyngeal swabs of individual patients to track viral spread. Recently, RT-qPCR of municipal wastewater has been used to quantify the abundance of SARS-CoV-2 in several regions globally. However, metatranscriptomic sequencing of wastewater can be used to profile the viral genetic diversity across infected communities. Here, we sequenced RNA directly from sewage collected by municipal utility districts in the San Francisco Bay Area to generate complete and near-complete SARS-CoV-2 genomes. The major consensus SARS-CoV-2 genotypes detected in the sewage were identical to clinical genomes from the region. Using a pipeline for single nucleotide variant (SNV) calling in a metagenomic context, we characterized minor SARS-CoV-2 alleles in the wastewater and detected viral genotypes which were also found within clinical genomes throughout California. Observed wastewater variants were more similar to local California patient-derived genotypes than they were to those from other regions within the US or globally. Additional variants detected in wastewater have only been identified in genomes from patients sampled outside of CA, indicating that wastewater sequencing can provide evidence for recent introductions of viral lineages before they are detected by local clinical sequencing. These results demonstrate that epidemiological surveillance through wastewater sequencing can aid in tracking exact viral strains in an epidemic context.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided to KLN and JFB by a Rapid Research Response grant from the Innovative Genomics Institute (IGI) and a seed grant from the Center for Information Technology Research in the Interest of Society (CITRIS) at UC Berkeley.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was required because there were no human subjects in the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSequencing data for this project has been released under NCBI BioProject ID PRJNA661613. Processed data, reproducible code, and workflows for the analyses performed have been made available at https://github.com/alexcritschristoph/wastewater_sarscov2. https://www.ncbi.nlm.nih.gov/bioproject/PRJNA661613 %U https://www.medrxiv.org/content/medrxiv/early/2020/09/14/2020.09.13.20193805.full.pdf